What Is New - Paediatric Rheumatological Conditions
Take a look at our 'What is new' highlights in paediatric rheumatology!
May 2022
"Psoriasis rate is increased by the exposure to TNF inhibition in children with JIA"
Why WIN?
This large analysis of real-world data, including >8000 children and young people with JIA, identified that the risk of new onset TNF inhibitor-associated psoriasis was ~5.6 times higher (adjusted for methotrexate, sex, race, family history of psoriasis, and ILAR) in those with non-psoriatic arthritis compared with those not treated with TNF inhibitors.
Interactive question
Would you be more likely to report new-onset psoriasis in JIA for those on TNFi – could this higher rate be influenced by reporting bias?
Yes/ No
Join the discussion on twitter... Share your response with us using the hastag #WhatIsNew and tag us @EMEUNET
December 2021
November 2021
October 2021
.jpg)
January 2021
December 2020
November 2020
October 2020
September 2020
February 2020
January 2020
December 2019
November 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
Click here to be directed to the article by Cann et al (2018).
August 2018
Childhood-onset rheumatic diseases / Bone health
Click here to be directed to the article by Inoue et al (2018).
July 2018
Juvenile localised scleroderma
Click here to be directed to the article by Agazzi et al (2018).
June 2018
Kawasaki Disease
Click here to be directed to the article by Zhang et al (2018).
May 2018
Juvenile myositis
Click here to be directed to the article by Yeker et al (2018).
April 2018
Juvenile idiopathic arthritis
Click here to be directed to the article by Höfel et al (2018).